{{Rsnum
|rsid=7008482
|Gene=NSMCE2
|Chromosome=8
|position=125255388
|Orientation=plus
|GMAF=0.4858
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=NSMCE2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 11.5 | 41.6 | 46.9
| HCB | 22.8 | 45.6 | 31.6
| JPT | 13.4 | 49.1 | 37.5
| YRI | 89.8 | 10.2 | 0.0
| ASW | 73.7 | 24.6 | 1.8
| CHB | 22.8 | 45.6 | 31.6
| CHD | 19.3 | 56.0 | 24.8
| GIH | 37.6 | 50.5 | 11.9
| LWK | 94.5 | 5.5 | 0.0
| MEX | 15.5 | 39.7 | 44.8
| MKK | 78.7 | 19.4 | 1.9
| TSI | 6.9 | 55.4 | 37.6
| HapMapRevision=28
}}Two genetic markers in the 8q24 region of chromosome 8 [[rs7008482]] and [[rs16901979]] have been linked to an increased risk of [[prostate cancer]] in African Americans. [http://www.genome.org/cgi/content/abstract/gr.6782707v1 abstract]

{{PMID Auto
|PMID=19520795
|Title=Novel Single Nucleotide Polymorphism Associations with Colorectal Cancer on Chromosome 8q24 in African and European Americans
|OA=1
}}

{{PMID Auto
|PMID=21051319
|Title=Risk of Urinary Bladder Cancer is Associated with 8q24 Variant rs9642880[T]: Results from the Los Angeles-Shanghai Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=22234922
|Title=8q24 risk alleles in West African and Caribbean men
|OA=1
}}

{{PMID Auto
|PMID=17978284
|Title=Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.
|OA=1
}}

{{PMID Auto
|PMID=19366828
|Title=Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
|OA=1
}}

{{PMID Auto
|PMID=19549807
|Title=Prostate cancer risk associated loci in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=19602258
|Title=Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}